GSK

Report: Glaxo withheld critical data on antidepressant Seroxat
BioPharma Dive
Fri, 09/18/15 - 11:28 am
GSK
antidepressants
Seroxat
There Appears to Be No Easy Path to Success for GlaxoSmithKline and Theravance
Motley Fool
Wed, 09/16/15 - 06:03 pm
GSK
Theravance
COPD
Breo Ellipta
Pharma Deal-Making: In The Pink Of Health
Seeking Alpha
Wed, 09/16/15 - 10:26 am
M&A
Baxalta
GSK
JNJ
Eli Lilly
Novartis
Perrigo
Shire
GlaxoSmithKline's Respiratory Line Not Dead At All
Seeking Alpha
Wed, 09/16/15 - 08:48 am
GSK
respiratory health
Big Pharma Hands Out Fitbits to Collect Better Personal Data
Bloomberg
Mon, 09/14/15 - 08:24 am
Big Pharma
Fitbit
Clinical Data
GSK
GlaxoSmithKline's 'Unexpected Disappointment'
Yahoo/Benzinga
Sun, 09/13/15 - 11:49 am
GSK
COPD
Breo
Big Pharma's 3 Most Perilous Pipelines
Motley Fool
Sat, 09/12/15 - 01:45 pm
Merck
GSK
Eli Lilly
Study finds key GSK-Theravance lung drug didn't extend lives
Yahoo/AP
Wed, 09/9/15 - 10:39 am
GSK
Theravance
Breo Ellipta
GlaxoSmithKline signs on LimmaTech for vaccine R&D
Fierce Vaccines
Thu, 09/3/15 - 06:45 pm
GSK
vaccines
R&D
LimmaTech
Adaptimmune pockets GSK payouts after tripling size of TCR trial
Fierce Biotech
Thu, 09/3/15 - 08:42 am
Adaptimmune
GSK
synovial sarcoma
NY-ESO-1
Novartis nabs EU approval for melanoma-fighting cocktail bought from GSK
Fierce Pharma
Tue, 09/1/15 - 06:35 pm
Novartis
Europe
melanoma
GSK
Mekinist
Tafinlar
Struggling GSK inks a translational deal with QB3
Fierce Biotech
Fri, 08/28/15 - 08:01 am
GSK
QB3
R&D
innovation
A Pivotal Moment For GlaxoSmithKline
Seeking Alpha
Thu, 08/27/15 - 11:26 am
GSK
Tivicay
Can Sprout's Addyi shrug off serious side effects? These blockbusters did
Fierce Pharma Marketing
Wed, 08/26/15 - 09:24 am
Sprout Pharmaceuticals
Addyi
female sexual dysfunction
side effects
Advair
GSK
Amgen
Epogen
Merck
Fosamax
Novartis snaps up MS indication for Glaxo's Arzerra
BioPharma Dive
Mon, 08/24/15 - 11:38 am
Novartis
MS
multiple sclerosis
GSK
Arzerra
GlaxoSmithKline plc, Bayer AG, Merck & Co. Among Pharmaceuticals Most Exposed To Emerging Market Turmoil
Bidness, ETC
Mon, 08/24/15 - 11:34 am
GSK
Bayer
Merck
emerging markets
Lilly, Sanofi, Novo among many pharma players to throw off big price gains in H1
Fierce Pharma
Sat, 08/22/15 - 08:48 am
Sanofi
Novo Nordisk
Eli Lilly
AstraZeneca
GSK
JNJ
stock prices
GlaxoSmithKline flips an MS project to Novartis for up to $1B
Fierce Biotech
Fri, 08/21/15 - 09:29 am
GSK
Novartis
MS
multiple sclerosis
ofatumumab
ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance Sheet
Seeking Alpha
Wed, 08/19/15 - 09:17 pm
GSK
ViiV Healthcare
Gilead
Pfizer
Bristol-Myers Squibb
HIV
A COPD outcomes trial could give GSK a $3B-plus Breo boost--or not
Fierce Pharma Marketing
Wed, 08/19/15 - 12:19 pm
COPD
GSK
Breo

Pages